StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3088.TWO$143.00+1.06%
Fair $143.00+0.0%

3088.TWO

Axiomtek Co., Ltd.

Technology / Computer HardwareTaipei Exchange

$143.00

+1.50 (+1.06%)

Fairly Valued+0.0%Fair Value $143.00Fund rank 35/100 · Data gapFallback financials|
SA 56/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $482.1M · quality 69.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 63/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

56/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3088.TWOLocal privado en este navegador · Axiomtek Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$15.5B

P/E

32.0x

↑

EV/EBITDA

16.1x

↑

ROE

9.7%

↑

Gross Margin

34.2%

↑

Debt/Equity

0.10

↓
52-Week Range$143
$72$152

TradingView lightweight chart

3088.TWO price, volumen y niveles de valoración

Último $143.00Periodo +227.2%
Fair value: $143.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+2.0%

FCF CAGR

+73.7%

FCF margin

5.8%

FCF / Net income

0.81x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.02B · net income $501.2M · FCF $407.0M

2022-FY → 2025-FY

Gross margin

34.2%+0.5% pts

Operating margin

10.0%-0.9% pts

Net margin

7.1%-2.0% pts

FCF margin

5.8%+4.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$7.02B$7.02B$6.89B$6.70B$6.62B
Net Income$501.2M$501.2M$768.9M$727.6M$602.6M
EBITDA$892.8M$892.8M$1.27B$1.13B$923.1M
EPS——6.926.865.93
Gross Margin34.2%34.2%36.8%35.9%33.7%
Operating Margin10.0%10.0%13.1%14.1%11.0%
Net Margin7.1%7.1%11.2%10.9%9.1%
Balance Sheet
Debt/Equity0.100.100.210.220.23
Current Ratio2.242.24———
Cash Flow
Free Cash Flow$407.0M$407.0M$687.3M$482.1M$77.7M
Returns
ROE9.7%9.7%16.6%17.3%17.0%
Valuation
P/E31.9931.9916.1812.499.10
EV/EBITDA16.1016.109.357.555.72
P/B2.992.992.722.171.54
Growth & Yield
Revenue Growth1.8%1.8%2.9%1.2%—
EPS Growth——0.9%15.7%—
Dividend Yield3.1%3.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +49.0%

Total return

+49.0%

Start / end P/E

n/dx → n/dx

EPS bridge

6.92 → n/d

Residual

+45.9%

EPS growthn/d
Multiple reratingn/d
Dividend+3.1%
Residual / FX / buybacks / cross-term+45.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.